NM_001195427.2(SRSF2):c.284C>G (p.Pro95Arg) AND Acute megakaryoblastic leukemia in down syndrome

Clinical significance:Likely pathogenic (Last evaluated: Sep 1, 2020)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:
current
Accession:
RCV001293765.1

Allele description [Variation Report for NM_001195427.2(SRSF2):c.284C>G (p.Pro95Arg)]

NM_001195427.2(SRSF2):c.284C>G (p.Pro95Arg)

Genes:
MFSD11:major facilitator superfamily domain containing 11 [Gene - HGNC]
SRSF2:serine and arginine rich splicing factor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q25.1
Genomic location:
Preferred name:
NM_001195427.2(SRSF2):c.284C>G (p.Pro95Arg)
HGVS:
  • NC_000017.11:g.76736877G>C
  • NG_032905.1:g.5535C>G
  • NM_001195427.2:c.284C>GMANE SELECT
  • NM_001242534.3:c.-286G>C
  • NM_001353017.2:c.-281G>C
  • NM_003016.4:c.284C>G
  • NP_001182356.1:p.Pro95Arg
  • NP_003007.2:p.Pro95Arg
  • LRG_640t1:c.284C>G
  • LRG_640:g.5535C>G
  • LRG_640p1:p.Pro95Arg
  • NC_000017.10:g.74732959G>C
  • NR_036608.2:n.455C>G
  • NR_148229.2:n.244G>C
  • NR_148230.2:n.244G>C
  • NR_148231.2:n.244G>C
Protein change:
P95R
Molecular consequence:
  • NM_001242534.3:c.-286G>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001353017.2:c.-281G>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001195427.2:c.284C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003016.4:c.284C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_036608.2:n.455C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148229.2:n.244G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148230.2:n.244G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148231.2:n.244G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
1

Condition(s)

Name:
Acute megakaryoblastic leukemia in down syndrome
Identifiers:
MONDO: MONDO:0020526; MedGen: CN207426

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001480518Genomic Diagnostic Laboratory, Division of Genomic Diagnostics,Children's Hospital of Philadelphiacriteria provided, single submitter
Likely pathogenic
(Sep 1, 2020)
somaticclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.

Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN.

J Mol Diagn. 2017 Jan;19(1):4-23. doi: 10.1016/j.jmoldx.2016.10.002. Review.

PubMed [citation]
PMID:
27993330
PMCID:
PMC5707196

Details of each submission

From Genomic Diagnostic Laboratory, Division of Genomic Diagnostics,Children's Hospital of Philadelphia, SCV001480518.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Oct 7, 2021

Support Center